Start: April 24, 2018
End: September 2021
Enrollment: 60
The Overture Study is a Phase I/II clinical trial to study safety, adherence rates, and efficacy of the Active GammaSense Stimulation System in older adults with mild cognitive impairment (MCI) and Alzheimer's disease. The device provides noninvasive auditory and visual sensory stimulation to the brain.
Minimum Age: 55 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Cognito Therapeutics, Inc.
Source: ClinicalTrials.gov ID: NCT03556280
An official website of the U.S. government, managed by the National Institutes on Aging at the National Institutes of Health